Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for cadonilimab in advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas [Phase 2]
Phase 2 trial investigating combined nivolumab and trabectedin in metastatic or inoperable soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial for localized high-risk rhabdomyosarcoma and rhabdomyosarcoma-like soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib with radiotherapy for resectable soft tissue sarcoma at high risk of recurrence.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating ipilimumab plus nivolumab with cryotherapy in soft tissue sarcoma has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: High Precision RT For Soft-Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating high-precision radiotherapy for soft-tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma [Phase 2]
Phase 2 trial update investigating apatinib mesylate in combination with doxorubicin and ifosfamide for advanced soft-tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases [Phase 1, Phase 2]
A Phase 1b/2 clinical trial evaluating liposomal annamycin in patients with soft tissue sarcoma and pulmonary metastases; current status is …
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Phase 2]
Phase 2 trial of pazopanib hydrochloride in advanced angiosarcoma has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A clinical trial update for durvalumab in combination with doxorubicin in advanced soft tissue sarcoma (Phase 1/2) with undisclosed status.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule [Phase 4]
A Phase 4 clinical trial assessing Anrotenil hydrochloride capsule as first-line chemotherapy after failure in soft tissue sarcoma has been …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Fruquintinib in the Treatment of Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for Fruquintinib in soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 3]
Phase 3 trial evaluating Anotinib hydrochloride with Epirubicin vs placebo with Epirubicin for first-line treatment of advanced soft tissue …
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating metronomic cyclophosphamide (CP) and JX-594 in patients with advanced breast cancer and advanced so…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.
A completed clinical trial evaluating a public health intervention program aimed at improving the initial management of soft tissue sarcomas…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical study evaluating recombinant anti-PD-1 antibody (609A) with doxorubicin for metastatic/unresectable soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A study of olaratumab (LY3012207) in participants with advanced soft tissue sarcoma completed Phase 1 and Phase 2 trials; results posted in …
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib [Phase 4]
Phase 4 trial evaluating quality of life in soft tissue sarcoma patients receiving palliative chemotherapy or pazopanib was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Cabozantinib for Adults With Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating cabozantinib in adults with refractory soft tissue sarcomas has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial investigating camrelizumab plus doxorubicin as first-line treatment for advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies [Phase 2]
Phase 2 trial update evaluating PDR001 plus LAG525 in patients with advanced solid and hematologic malignancies; results posted with complet…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall [Phase 2, Phase 3]
A Phase 2/3 trial evaluating NBTXR3 crystalline nanoparticles with radiation therapy in adults with soft tissue sarcoma of the extremity and…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 trial update for axitinib in advanced angiosarcoma and other soft tissue sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma [Phase 3]
A Phase 3 randomized trial evaluating different volumes of post-operative radiotherapy in adult extremity soft tissue sarcoma has been compl…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas [Phase 2]
Phase 2 study of TAK-228 (MLN0128) in soft tissue sarcoma was terminated; results posted.